Health Archive » February, 2007

Health - February, 2007

124 articles

• C.R. Bard Hit With Antitrust, Product Liability Suits
• Celgene, Novartis File Suit Against Generic Ritalin
• Siemens Attorney, Former Exec Plead Guilty To Fraud
• IntraLase Drops Appeal, Pays Escalon $9.6M
• Changes In Medicare Payments For Long-Term Care
• Bristol-Myers Off The Hook In Plavix Probe
• Mylan Loses Fight For Generic Hypertension Drug
• Former FDA Head Gets Probation, Fine
• Final HIPAA Nondiscrimination Regulations Issued
• Ruling Issued On Eye Surgery Patent
• McKesson Unit Settles For $18.7M
• Appeals Court Backs Stem Cell Agency
• Pipette Maker Claims Rival Infringed Patents
• Japan To Probe Purported Tamiflu Child Suicides
• Problems With MRI Lease Agreements
• Caremark/CVS Merger Ruling Gets Praise
• Pfizer Loses Bid To Dismiss Adversary Proceeding
• Suit Challenges FDA's Authority Over Cancer Drugs
• Merck Vaccine Sparks Lawsuit
• New HHS Guidelines Clarify Adverse Event Reporting
• Attorneys Spared Costs In Cardizem Case
• Ex-HealthSouth CFO Dodges Prison Time
• Medco Health Unit Settles Overbilling Suit For $5.3M
• Sale Of Generic Lipitor Blocked In Denmark
• SonoSite, Zonare Clash Over Ultrasound Patent
• Spat Over Cold Medicine Leads To Suits
• Caraco Seeks Judgment On Lexapro Patent
• Merck Donated To Vaccine-Friendly Governor: Report
• ITC Judge To Rehear Smallpox Patent Fight
• USPTO Delivers Setback To Genentech
• Hospital Sued For Washing Scalpels In Elevator Fluid
• ADHD Drug Makers Must Warn Of Side Effects: FDA
• Suits Pile Up Over Human Tissue
• Ex-Biopure CEO Settles Blood Substitute Case
• Using Citizen Petitions To Harm Competition
• Medical Device Co. Receives FDA Warning
• Catheter Maker Seeks To Overturn Jury Verdict
• Merck Backs Away From Gardasil Lobbying
• HealthSouth Fails To Shoot Down $376M Suit
• Serono Agrees To $24M Settlement Over AIDS Drug
• UNITE HERE Under Fire From Hospital
• Hungarian Drug Maker Triumphs Over Merck
• Restless Leg Drug Triggers Gambling Habit: Suits
• Enzyme Patent Dispute Settled For $8.2M
• Wyeth Loses 2nd Prempro Trial; Jury Awards $3M
• HHS Needs Clear Plan To Protect Patient Privacy
• Judge Approves SeraCare Reorganization Plan
• AAI Cautions FTC On Carmark-Express Scripts Union
• Testimony Wraps Up In Plavix Trial
• Government Raids Ranbaxy's Offices
• Pfizer Drug Supply Deal Draws Antitrust Scrutiny
• Novartis Tightens Stance Over Gleevec In India
• Merck Agrees To $2.3B Settlement With IRS
• Solutia Creditors Seek To Force Mediation
• Genetic Discrimination Bill Makes Headway
• Appeals Court Hears Opposition To Stem Cell Institute
• Injunction Issued Over Zyprexa Leak
• Wyeth Garners Victory In Prempro Trial
• Generic Biologics Bill Reintroduced
• Employment Litigation Trends: Health Care
• IP Litigation Trends: Health Care
• Securities Litigation Trends: Health Care
• Antitrust Litigation Trends: Health Care
• Product Liability Litigation Trends: Health Care
• America's Most Litigious Health Care Companies
• Number Of Suits Against Medtronic Spikes
• Judge Calls For New Trial In Fresenius Case
• J&J Staves Off Generic Topamax
• Realtors Sue Blue Shield For Cutting Health Plan
• Abbott Ordered To Pay $6M In Discrimination Suit
• FDA Restricts Use Of Sanofi-Aventis Drug
• Court Halts Caremark-CVS Merger Vote
• J&J May Have Violated Foreign Corrupt Practices Act
• Sanofi-Aventis To Appeal Lovenox Verdict
• Australia's Top Court To Hear Antitrust Test Case
• Sealed Documents Challenged In Zyprexa Case
• Patent Attorney, Firm Sued For Malpractice
• St. Vincent Files Reorganization Plan
• FDA, Cardinal Strike Deal On Defective Drug Pumps
• Thailand Threatens More Compulsory Licenses
• Glaxo, Watson Strike $35M Deal Over Wellbutrin
• The Future Of "Pay-Or-Play"
• Apotex Head Fires Back In Ownership Feud
• QLT Unit Pays $112.5M To Resolve Drug Dispute
• Sanofi-Aventis Dealt A Setback
• Canadian Supreme Court Dismisses Abbott's Appeal
• Judge OK's $5M Amerigroup Settlement
• Court Grants Hemosol Stay
• AMS Settles With Celsion Over Prostate Product
• Amgen Ponders Whether To Seek Injunction
• Australia Vows To Shield Blood Plasma Market
• 30 Pharma Cos. Sued In Turkey
• Medical Device Co. Pulls Endoscopes
• Hospitals Skirting Iowa Review Law, Insurer Says
• Siemens Unit Admits To Concealing Sham Deal
• Family Charged In $3.7M Insider-Trading Scheme
• Female EMS Workers Allege Discrimination
• Matrix Latest Target In Teva's Zoloft Battle
• PwC To Pay $10M, Avoids Larger Setback
• AG Urges Delay Of UnitedHealth Settlement
• UnitedHealth Hit With Sweeping RICO Suit
• Roche Says It Will Launch Mircera
• Accused Of Destroying Company, Lawyer Strikes Deal
• Pfizer Appeals Viagra Ruling In China
• J&J Closes Acquisition After Injunction Is Denied
• Appeal Zapped In Laser Surgery Trade Secrets Case
• Sanofi-Aventis Sues Synthon Over Generic Ambien
• King & Spalding Boosts Health Care Group
• Abbott Labs Files Patent Suit Against ImClone
• Pfizer's Viagra Case Withers In China
• Class Action Against Medical Device Maker Tossed
• CVS Warns Rival Bid Riddled With Antitrust Issues
• Law Means More Headaches, Suits For Employers
• Court Affirms BrainLAB's Win Against Medtronic
• Wyeth Notches Victory In Texas Prempro Suit
• Glaxo Seeks Ban on Ranbaxy's Herpes Drug
• Judge Reverses Return Of Disclosed E-mails
• Senators Propose Host Of Changes For Drug Industry
• Avian Flu Vaccine Makers Exempt From Liability
• Federal Circuit Says U.S. Can't Decide Foreign Patents
• St. Vincent Gets Exclusivity Extension
• PTO Shoots Down Benitec's Patent Claims
• Medtronic Sues Over Alloy Device Patents
• Pharmacy Board Retreats From Generic Opposition